Mounjaro injection sites
Mounjaro injection sites, straight from the label
The Mounjaro injection sites are the abdomen, the thigh and, when someone else gives the injection, the back of the upper arm, with a different site for every dose. Zepbound, the same medicine under its US weight-management name, follows the same rules. Here is what the label says, what it doesn't, and how to keep track.
On this page
- Where you can inject Mounjaro and Zepbound
- Is there a best Mounjaro injection site?
- How to rotate Mounjaro injection sites
- Mounjaro pens and vials: label facts worth knowing
- Mounjaro injection site reactions: how common are they?
- When to contact your care team about a reaction
- Using the Mounjaro jab in the UK
- Questions to ask your care team about injecting
- Questions people ask
- Sources
In short
- Mounjaro injection sites, as the US prescribing information lists them, are the abdomen, the thigh, and the back of the upper arm when another person gives the injection.1
- The label asks you to rotate injection sites with each dose, and Zepbound — the same medicine, tirzepatide, sold in the US for weight management — gives the same instructions.1,2
- The label doesn't rank the sites: it reports similar tirzepatide exposure whether the injection goes into the abdomen, thigh or upper arm.1
- Injection-site reactions were reported by 3.2% of adults on Mounjaro in its placebo-controlled diabetes trials, against 0.4% on placebo, and by 6–8% of people on Zepbound in its 72-week weight-management trials, against 2%.1,2
- Handle records the site with every dose and shows where you injected last time, so rotating is easy to follow — it never tells you which site to use.
Where you can inject Mounjaro and Zepbound
Both labels list the same three areas, in almost the same words. Every injection goes under the skin — subcutaneously, in the label's language.1,2
| What the labels say | How Handle records it | |
|---|---|---|
| Abdomen (stomach area) | Listed for Mounjaro and Zepbound1,2 | Left or right abdomen |
| Thigh | Listed for Mounjaro and Zepbound1,2 | Left or right thigh |
| Back of the upper arm | Mounjaro: "have another person inject" there. Zepbound: "another person should inject" there.1,2 | Left or right upper arm |
| Rotation | "Rotate injection sites with each dose."1,2 | Your last site is shown when you log |
Quoted from each medicine's US prescribing information. The Instructions for Use that comes with your pen or vial covers the injection itself. On Ozempic or Wegovy? See Ozempic and Wegovy injection sites.
Is there a best Mounjaro injection site?
Not according to the label. It lists the three areas without ranking them, asks you to rotate with each dose, and reports similar tirzepatide exposure whether the injection goes into the abdomen, thigh or upper arm.1 Searches for the "best site for results" are asking a question the label answers with rotation, not with a favorite.
Practical reasons still count: which areas you can reach comfortably, whether someone can help with your arm, and whether one spot tends to react. They are good reasons to choose, not signs that one site works better.
Common claims, next to the label
| You may read | What the label says |
|---|---|
| "The stomach gives the best weight loss." | All three areas are listed side by side, with similar tirzepatide exposure from each.1 |
| "The thigh causes fewer side effects." | The label links no site to fewer side effects. Most reports of nausea, vomiting and diarrhea came while the dose was being stepped up, and decreased over time.1 More in Mounjaro side effects. |
| "Stick to one spot so you don't lose track." | Rotate injection sites with each dose.1 |
| "You can't use your arm." | The back of the upper arm is listed, for when another person gives the injection.1 |
| "A new site will restart stalled weight loss." | The label doesn't present a site change as a way to change results.1 A plateau is a conversation for your prescriber. |
How to rotate Mounjaro injection sites
Rotating means each dose goes into a different site from the one before.1 Once a week, it takes seconds.
- 1Know your areas
The abdomen and thighs, plus the back of the upper arm if someone can inject for you.1 Handle splits them into left and right: six sites, or four if you always inject yourself.
- 2Look back first
Open the log before you inject, and Handle shows the site you used last time.
- 3Choose somewhere different
The label sets no order; the site just has to change.1 Some people find a simple pattern easier to remember, such as moving around the areas they use in the same order. Your prescriber or nurse can help you choose the sites that suit you.
- 4Save it with the dose
The site goes on your record with the amount and time, ready for next week.
- 5Notice how the skin settles
If the spot reacts, the site and date help your care team see whether it happens in one area or in any area.
In Handle
See last week's site before you choose this week's
Handle's site picker is a simple body map: abdomen, thighs and upper arms, left and right. When you log a Mounjaro or Zepbound dose, it shows where you injected last time, so choosing somewhere different takes a second.
- Six sites on one body map, left and right
- Your previous site shown every time you log
- Handle never picks a site for you or claims one works better
- Oral medicines are recorded without a site
Mounjaro pens and vials: label facts worth knowing
In the US, Mounjaro and Zepbound each come as a single-dose pen, a single-dose vial, a four-dose multi-dose vial and a four-dose KwikPen.1,2 The injection areas are the same for all of them. A few handling rules from the labels:
- Vials: use a new syringe and needle for every injection.1,2
- KwikPen: never share one with another person, even if the needle is changed. It isn't recommended for self-injection by people who are visually impaired, or, on the Mounjaro label, by children.1,2
- Every form: never freeze it, and don't use one that has been frozen.1,2
- New device? Ask for a quick run-through, even if the medicine and your plan are unchanged.1,2
In Handle
Log the dose and the site in one go
Your prescribed plan is already in Handle, so injection day is quick: confirm the amount and the time, tap the site, done. Reminders in the iPhone app can nudge you on the day, if you want them. More in our Mounjaro tracker and Zepbound tracker guides.
- Amount, time and site in a single entry
- Mounjaro and Zepbound both listed by name
- Forgot to log? Add it later, up to 30 days back, with its real date
- No streaks and no scores
Mounjaro injection site reactions: how common are they?
An injection-site reaction is irritation of the skin where the needle went in — redness, itching, soreness or bruising, for example.2 Mounjaro's label reports them in 3.2% of adults in its placebo-controlled type 2 diabetes trials, against 0.4% on placebo.1 In Zepbound's 72-week weight-management trials, the figure was 6% to 8% depending on the dose, against 2% on placebo.2
Allergic reactions are a separate warning. Hypersensitivity reactions of any kind were reported by 3.2% of adults on Mounjaro against 1.7% on placebo in the same diabetes trials, and severe ones by 0.1% of people on Zepbound in its weight-management trials, against none on placebo.1,2 Serious reactions, including anaphylaxis and angioedema, have been reported with tirzepatide.1 For the full lists, see Zepbound side effects and GLP-1 side effects.
Injection-site reactions in the tirzepatide trials
| Label and trial pool | Placebo | Tirzepatide |
|---|---|---|
| Mounjaro: adults with type 2 diabetes, placebo-controlled trials1 | 0.4% | 3.2% |
| Zepbound 5 mg: adults with obesity or overweight, up to 72 weeks2 | 2% | 6% |
| Zepbound 10 mg: the same trials2 | 2% | 8% |
| Zepbound 15 mg: the same trials2 | 2% | 8% |
The Zepbound trials, SURMOUNT-1 and SURMOUNT-2, included people with and without type 2 diabetes.3 The pools studied different people for different lengths of time, so the rows are not a head-to-head comparison.2
When to contact your care team about a reaction
Most people in the trials had no injection-site reaction. Still, get in touch with your prescriber, nurse or pharmacist, rather than waiting for your next appointment, if a reaction:
- Isn't settling. It lasts, or gets worse instead of better.
- Keeps coming back. Week after week, especially in one area.
- Spreads. Redness, swelling or itching reaches well beyond the spot you used.
- Leaves the skin changed. A lump, dent or hard patch doesn't go away.
- Worries you. If you can't tell whether something is normal, asking is always reasonable.
Say which site, which day and what you saw: a pattern is easier to spot on a list than from memory. Handle keeps the site and date of every dose, and your daily check-in can track a symptom in your own words. It doesn't judge reactions; that's your care team's job.
In Handle
Every dose on one record you can scroll back through
Each dose you log stays on your record with its date, time and amount, and injections keep their site. When a spot reacts, or a question comes up at an appointment, the answer is a scroll away. That record is the heart of any good weight-loss injection tracker.
- Date, time, amount and site for every injection
- Change medicines and both stay on one record
- No advertising, and Handle does not sell personal information
Using the Mounjaro jab in the UK
In the UK, Mounjaro is the tirzepatide brand for both type 2 diabetes and weight management; the Zepbound name isn't used.3 The MHRA authorised the weight-management use in November 2023 and approved a four-dose Mounjaro KwikPen in January 2024.3,4
The areas on this page come from the US prescribing information. Your UK pack has its own leaflet: if anything there reads differently, follow the leaflet and ask your pharmacist. However your jab is supplied, Handle records it the same way. Weighing up options? See Mounjaro vs Wegovy.
Questions to ask your care team about injecting
- Can you show me how to inject with the pen or vial I've been given?
- Is the back of my upper arm an option if someone at home can help?
- Which reactions should I call you about, and which can wait for my next appointment?
Questions people ask
Where do you inject Mounjaro?+
Under the skin of your abdomen or thigh, or the back of your upper arm if another person gives the injection. Those are the areas in the Mounjaro prescribing information, which also asks you to rotate injection sites with each dose.1 Handle shows where you went last time, so choosing a different site is easy.
Is it better to inject Mounjaro in the stomach or thigh?+
The label doesn't favor either. It lists the abdomen and thigh side by side and reports similar tirzepatide exposure from the abdomen, thigh and upper arm.1 What it does ask is that the site changes with each dose. If one area is easier for you, or one tends to react, talk it through with your care team.
Does the injection site affect weight loss on Mounjaro or Zepbound?+
The label gives no reason to think so: tirzepatide exposure is similar across the abdomen, thigh and upper arm, and it asks you to rotate sites with each dose.1,2 If your weight has stopped changing, a new site isn't a fix the label offers. Your prescriber can look at the whole picture with you.
Why does my Mounjaro injection site itch?+
Itching where you injected can be an injection-site reaction. Mounjaro's label reports these in 3.2% of adults in its diabetes trials (0.4% on placebo), and Zepbound's in 6–8% of people in its weight trials (2% on placebo).1,2 Tell your care team if it keeps happening or spreads. Get medical help right away for severe itching or rash, or swelling of your face, lips, tongue or throat.1
Can you inject Mounjaro in the same spot twice?+
Not two doses in a row. The label asks you to rotate injection sites with each dose, so each injection goes into a different site from the one before.1 Handle shows where you injected last time whenever you log a dose, so you never have to rely on memory to keep the pattern going.
Can I inject Mounjaro in my arm myself?+
The labels keep the back of the upper arm for when another person gives the injection: Mounjaro's says to "have another person inject" there, and Zepbound's that "another person should inject" there.1,2 On your own, the abdomen and thigh are the areas described. Your care team can show whoever helps you how to use your pen or vial.
Are Zepbound injection sites the same as Mounjaro's?+
Yes. Zepbound is the same medicine, tirzepatide, from the same maker, sold in the US for weight management and obstructive sleep apnea. Its label lists the same three areas, including the back of the upper arm when another person injects, and the same instruction to rotate with each dose.1,2 Compare the two brands in Mounjaro vs Zepbound.
Does Handle tell me where to inject next?+
No. Handle records the site you chose — left or right abdomen, thigh or upper arm — and shows where you injected last time. It never picks your next site or claims that one works better; that choice stays with you and your care team. Oral medicines are recorded without a site.
Sources
- Eli Lilly and Company, via DailyMed (U.S. National Library of Medicine). Mounjaro (tirzepatide) injection — Prescribing Information and Medication Guide, effective August 27, 2026.
- Eli Lilly and Company, via DailyMed (U.S. National Library of Medicine). Zepbound (tirzepatide) injection — Prescribing Information and Medication Guide, effective August 28, 2026.
- Medicines and Healthcare products Regulatory Agency (UK). MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss, November 8, 2023.
- Medicines and Healthcare products Regulatory Agency (UK). Four-dose Mounjaro “KwikPen” approved by MHRA for diabetes and weight management, January 25, 2024.
Written by the Handle team from the sources above, last checked on September 23, 2026. How we write: our editorial policy. Spotted something out of date? Tell us at [email protected].
Handle supports recording and conversations with your care team. It does not diagnose, and it never tells you to start, change, skip or stop a dose. This page is general information, not medical advice. Always follow your prescriber and your medicine's instructions for use.